Kress Jean-Paul
SEC insider (Form 3/4/5 filer). CIK 0001654979. CEO and Chairman at Vor Biopharma Inc. (VOR). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 5, 2025. Located in CAMBRIDGE, MA.
Companies Kress Jean-Paul has filed insider reports for
- Vor Biopharma Inc. (VOR): Director, Officer, CEO and Chairman
Kress Jean-Paul
CIK: 0001654979
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VOR
Vor Biopharma Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 5, 2025VOR
Vor Biopharma Inc.
DispositionDirectEmployee Stock Option (right to buy)
4.2M shares- - Dec 5, 2025VOR
Vor Biopharma Inc.
AwardDirectEmployee Stock Option (right to buy)
4.2M shares- - Jun 26, 2025VOR
Vor Biopharma Inc.
AwardDirectEmployee Stock Option (right to buy)
83.3M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 5, 2025 | VOR Vor Biopharma Inc. | Disposition Employee Stock Option (right to buy) | 4,164,831 | - | - | Direct |
| Dec 5, 2025 | VOR Vor Biopharma Inc. | Award Employee Stock Option (right to buy) | 4,164,831 | - | - | Direct |
| Jun 26, 2025 | VOR Vor Biopharma Inc. | Award Employee Stock Option (right to buy) | 83,296,638 | - | - | Direct |
1-3 of 3 transactions